Elevated CSF sPDGFRβ in AD is thought to reflect ADAM‐10‐mediated shedding of cell‐surface PDGFRβ from pericytes13 in response to Aβ and tau, as demonstrated in vitro and in vivo (reviewed in Kim et al.2 This evidence concerns the gene MAPT and Alzheimer disease.